238 related articles for article (PubMed ID: 8001348)
1. African horse sickness virus structure.
Roy P; Mertens PP; Casal I
Comp Immunol Microbiol Infect Dis; 1994; 17(3-4):243-73. PubMed ID: 8001348
[TBL] [Abstract][Full Text] [Related]
2. The complete sequence of four major structural proteins of African horse sickness virus serotype 6: evolutionary relationships within and between the orbiviruses.
Williams CF; Inoue T; Lucus AM; Zanotto PM; Roy P
Virus Res; 1998 Jan; 53(1):53-73. PubMed ID: 9617769
[TBL] [Abstract][Full Text] [Related]
3. Evolutionary relationships among the gnat-transmitted orbiviruses that cause African horse sickness, bluetongue, and epizootic hemorrhagic disease as evidenced by their capsid protein sequences.
Iwata H; Yamagawa M; Roy P
Virology; 1992 Nov; 191(1):251-61. PubMed ID: 1329319
[TBL] [Abstract][Full Text] [Related]
4. Structural Protein VP2 of African Horse Sickness Virus Is Not Essential for Virus Replication In Vitro.
van Gennip RGP; van de Water SGP; Potgieter CA; van Rijn PA
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903804
[TBL] [Abstract][Full Text] [Related]
5. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the genes encoding two of the major capsid proteins of epizootic haemorrhagic disease virus indicates a close genetic relationship to bluetongue virus.
Iwata H; Chuma T; Roy P
J Gen Virol; 1992 Apr; 73 ( Pt 4)():915-24. PubMed ID: 1321879
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization.
Martinez-Torrecuadrada JL; Iwata H; Venteo A; Casal I; Roy P
Virology; 1994 Jul; 202(1):348-59. PubMed ID: 8009847
[TBL] [Abstract][Full Text] [Related]
8. Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV).
van Rijn PA; van de Water SG; Feenstra F; van Gennip RG
Virol J; 2016 Jul; 13():119. PubMed ID: 27368544
[TBL] [Abstract][Full Text] [Related]
9. Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes.
Lulla V; Lulla A; Wernike K; Aebischer A; Beer M; Roy P
J Virol; 2016 Aug; 90(16):7405-7414. PubMed ID: 27279609
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the genes which encode non-structural protein NS3 of different orbiviruses.
van Staden V; Huismans H
J Gen Virol; 1991 May; 72 ( Pt 5)():1073-9. PubMed ID: 2033391
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide sequence comparison of the segments S10 of the nine African horsesickness virus serotypes.
Sailleau C; Moulay S; Zientara S
Arch Virol; 1997; 142(5):965-78. PubMed ID: 9191861
[TBL] [Abstract][Full Text] [Related]
12. Phylogenetic analysis of African horse sickness virus segment 10: sequence variation, virulence characteristics and cell exit.
Martin LA; Meyer AJ; O'Hara RS; Fu H; Mellor PS; Knowles NJ; Mertens PP
Arch Virol Suppl; 1998; 14():281-93. PubMed ID: 9785513
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of African horse sickness virus based on analyses and comparisons of genome segments 7 and 10.
Zientara S; Sailleau C; Plateau E; Moulay S; Mertens PP; Crucière C
Arch Virol Suppl; 1998; 14():221-34. PubMed ID: 9785509
[TBL] [Abstract][Full Text] [Related]
14. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
[TBL] [Abstract][Full Text] [Related]
15. Genetic relationships of bluetongue virus serotypes isolated from different parts of the world.
Ritter DG; Roy P
Virus Res; 1988 Aug; 11(1):33-47. PubMed ID: 2845682
[TBL] [Abstract][Full Text] [Related]
16. Expression of nonstructural protein NS3 of African horsesickness virus (AHSV): evidence for a cytotoxic effect of NS3 in insect cells, and characterization of the gene products in AHSV infected Vero cells.
van Staden V; Stoltz MA; Huismans H
Arch Virol; 1995; 140(2):289-306. PubMed ID: 7710356
[TBL] [Abstract][Full Text] [Related]
17. A comparison of different orbivirus proteins that could affect virulence and pathogenesis.
Huismans H; van Staden V; Fick WC; van Niekerk M; Meiring TL
Vet Ital; 2004; 40(4):417-25. PubMed ID: 20422564
[TBL] [Abstract][Full Text] [Related]
18. Development of a mouse model system, coding assignments and identification of the genome segments controlling virulence of African horse sickness virus serotypes 3 and 8.
O'Hara RS; Meyer AJ; Burroughs JN; Pullen L; Martin LA; Mertens PP
Arch Virol Suppl; 1998; 14():259-79. PubMed ID: 9785512
[TBL] [Abstract][Full Text] [Related]
19. Characterising Non-Structural Protein NS4 of African Horse Sickness Virus.
Zwart L; Potgieter CA; Clift SJ; van Staden V
PLoS One; 2015; 10(4):e0124281. PubMed ID: 25915516
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
van Rijn PA; Maris-Veldhuis MA; Boonstra J; van Gennip RGP
Vaccine; 2018 Jun; 36(25):3584-3592. PubMed ID: 29759377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
